
Jacob Sten Petersen
Jacob Sten Petersen has been Senior Vice President as Head of Global Nucleic Acid Therapies since 2023, responsible for RNAi modality and gene editing modality platform. He joined the Board of Directors of Novo Nordisk Pharmatech A/S in 2021. Mr. Petersen joined Novo Nordisk in 2001 as CVP for Global Research Metabolic